Related references
Note: Only part of the references are listed.The Metabolic Mechanisms of Breast Cancer Metastasis
Lingling Wang et al.
FRONTIERS IN ONCOLOGY (2021)
TGLI1 transcription factor mediates breast cancer brain metastasis via activating metastasis-initiating cancer stem cells and astrocytes in the tumor microenvironment
Sherona R. Sirkisoon et al.
ONCOGENE (2020)
Subtype switching in breast cancer brain metastases: a multicenter analysis
Alexander F. C. Hulsbergen et al.
NEURO-ONCOLOGY (2020)
Estrogen/progesterone receptor and HER2 discordance between primary tumor and brain metastases in breast cancer and its effect on treatment and survival
Paul W. Sperduto et al.
NEURO-ONCOLOGY (2020)
Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial
Nancy U. Lin et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study
Sandra M. Swain et al.
LANCET ONCOLOGY (2020)
SOX2 Promotes Brain Metastasis of Breast Cancer by Upregulating the Expression of FSCN1 and HBEGF
Weikai Xiao et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
The genomic landscape of breast cancer brain metastases: a systematic review
Alexander J Morgan et al.
LANCET ONCOLOGY (2020)
The diagnostic value of DNA repair gene in breast cancer metastasis
Yongxin Yang et al.
SCIENTIFIC REPORTS (2020)
Clinical outcomes of breast leptomeningeal disease treated with intrathecal trastuzumab, intrathecal chemotherapy, or whole brain radiation therapy
Nicholas B. Figura et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment
Ana C. Garrido-Castro et al.
CANCER DISCOVERY (2019)
A Comparison of DNA Mutation and Copy Number Profiles of Primary Breast Cancers and Paired Brain Metastases for Identifying Clinically Relevant Genetic Alterations in Brain Metastases
Marguerite Tyran et al.
CANCERS (2019)
Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort
Amelie Darlix et al.
BRITISH JOURNAL OF CANCER (2019)
Metabolic crosstalk in the breast cancer microenvironment
Ana S. Dias et al.
EUROPEAN JOURNAL OF CANCER (2019)
Brain metastases
Achal Singh Achrol et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Clonality of circulating tumor cells in breast cancer brain metastasis patients
Carlotta Riebensahm et al.
BREAST CANCER RESEARCH (2019)
Breast cancer brain metastases snow increased levels of genomic aberration-based homologous recombination deficiency scores relative to their corresponding primary tumors
M. Diossy et al.
ANNALS OF ONCOLOGY (2018)
Targeting Brain-Adaptive Cancer Stem Cells Prohibits Brain Metastatic Colonization of Triple-Negative Breast Cancer
Ding Ren et al.
CANCER RESEARCH (2018)
Loss of XIST in Breast Cancer Activates MSN-c-Met and Reprograms Microglia via Exosomal miRNA to Promote Brain Metastasis
Fei Xing et al.
CANCER RESEARCH (2018)
Tyrosine kinase inhibitors for brain metastases in HER2-positive breast cancer
Renata Duchnowska et al.
CANCER TREATMENT REVIEWS (2018)
Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing
Charissa Kim et al.
CELL (2018)
Phase I feasibility study for intrathecal administration of trastuzumab in patients with HER2 positive breast carcinomatous meningitis
Claire Bonneau et al.
EUROPEAN JOURNAL OF CANCER (2018)
Profiles of brain metastases: Prioritization of therapeutic targets
Sherise D. Ferguson et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Molecular subtype predicts incidence and prognosis of brain metastasis from breast cancer in SEER database
Yi-Jun Kim et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Integrated RNA and DNA sequencing reveals early drivers of metastatic breast cancer
Marni B. Siegel et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Breast cancer brain metastasis: molecular mechanisms and directions for treatment
Rute M. S. M. Pedrosa et al.
NEURO-ONCOLOGY (2018)
Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer
Sherona R. Sirkisoon et al.
ONCOGENE (2018)
Genetic heterogeneity and actionable mutations in HER2-positive primary breast cancers and their brain metastases
Charlotte K. Y. Ng et al.
Oncotarget (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Intrathecal Viral Vector Delivery of Trastuzumab Prevents or Inhibits Tumor Growth of Human HER2-Positive Xenografts in Mice
William T. Rothwell et al.
CANCER RESEARCH (2018)
Phase Ib/II single-arm trial evaluating the combination of everolimus, lapatinib and capecitabine for the treatment of HER2-positive breast cancer with brain metastases (TRIO-US B-09)
Sara Hurvitz et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
PTEN mediates the cross talk between breast and glial cells in brain metastases leading to rapid disease progression
Ina Hohensee et al.
ONCOTARGET (2017)
The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation
David P. Kodack et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Current challenges in the management of breast cancer brain metastases
Ciara C. O'Sullivan et al.
SEMINARS IN ONCOLOGY (2017)
ATM kinase sustains breast cancer stem-like cells by promoting ATG4C expression and autophagy
Martina Antonelli et al.
ONCOTARGET (2017)
Brain Metastases in Newly Diagnosed Breast Cancer A Population-Based Study
Allison M. Martin et al.
JAMA ONCOLOGY (2017)
Discordance and Conversion Rates of Progesterone-, Estrogen-, and HER2/neu-Receptor Status in Primary Breast Cancer and Brain Metastasis Mainly Triggered by Hormone Therapy
Marco Timmer et al.
ANTICANCER RESEARCH (2017)
Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer
Juan M. Cejalvo et al.
CANCER RESEARCH (2017)
Estrogen promotes the brain metastatic colonization of triple negative breast cancer cells via an astrocyte-mediated paracrine mechanism
C. A. Sartorius et al.
ONCOGENE (2016)
Prognostic values of Notch receptors in breast cancer
Junming Xu et al.
TUMOR BIOLOGY (2016)
Brain metastasis in breast cancer: a comprehensive literature review
Rezvan Rostami et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer
Qing Chen et al.
NATURE (2016)
Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
Jingdan Qiu et al.
JOURNAL OF CANCER (2016)
Gene Expression Profiling of Breast Cancer Brain Metastasis
Ji Yun Lee et al.
SCIENTIFIC REPORTS (2016)
Exosomal miRNAs as cancer biomarkers and therapeutic targets
Arron Thind et al.
JOURNAL OF EXTRACELLULAR VESICLES (2016)
Breast Cancer Subtypes Predispose the Site of Distant Metastases
Abha Soni et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2015)
Emerging Strategies for Treating Brain Metastases from Breast Cancer
David P. Kodack et al.
CANCER CELL (2015)
Breast Cancer With Brain Metastases: Clinicopathologic Features, Survival, and Paired Biomarker Analysis
Qi Shen et al.
ONCOLOGIST (2015)
ATM kinase sustains HER2 tumorigenicity in breast cancer
Venturina Stagni et al.
NATURE COMMUNICATIONS (2015)
Cytogenomic profiling of breast cancer brain metastases reveals potential for repurposing targeted therapeutics
Aliccia Bollig-Fischer et al.
ONCOTARGET (2015)
Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer
Ji Yun Lee et al.
ONCOTARGET (2015)
The gain-of-function GLI1 transcription factor TGLI1 enhances expression of VEGF-C and TEM7 to promote glioblastoma angiogenesis
Richard L. Carpenter et al.
ONCOTARGET (2015)
An EGFR/Src-dependent β4 integrin/FAK complex contributes to malignancy of breast cancer
Yu-Ling Tai et al.
SCIENTIFIC REPORTS (2015)
A phase I trial of combination trastuzumab, lapatinib, and bevacizumab in patients with advanced cancer
Gerald S. Falchook et al.
INVESTIGATIONAL NEW DRUGS (2015)
Expression of Notch1 Correlates with Breast Cancer Progression and Prognosis
Xun Yuan et al.
PLOS ONE (2015)
Molecular Classification of Breast Carcinoma: From Traditional, Old-Fashioned Way to A New Age, and A New Way
Nuket Eliyatkin et al.
JOURNAL OF BREAST HEALTH (2015)
Metastatic Stem Cells: Sources, Niches, and Vital Pathways
Thordur Oskarsson et al.
CELL STEM CELL (2014)
DNA Double-Strand Break Repair Genes and Oxidative Damage in Brain Metastasis of Breast Cancer
Stephan Woditschka et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Discovery of Biomarkers Predictive of GSI Response in Triple-Negative Breast Cancer and Adenoid Cystic Carcinoma
Alexander Stoeck et al.
CANCER DISCOVERY (2014)
A BRCA1 deficient-like signature is enriched in breast cancer brain metastases and predicts DNA damage-induced poly (ADP-ribose) polymerase inhibitor sensitivity
Ryan P. McMullin et al.
BREAST CANCER RESEARCH (2014)
Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potential
Helene Pelicano et al.
BREAST CANCER RESEARCH (2014)
Frequent Genetic Alterations in EGFR- and HER2-Driven Pathways in Breast Cancer Brain Metastases
Ina Hohensee et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Optical Metabolic Imaging Identifies Glycolytic Levels, Subtypes, and Early-Treatment Response in Breast Cancer
Alex J. Walsh et al.
CANCER RESEARCH (2013)
The expression and clinical significance of microRNA-1258 and heparanase in human breast cancer
Dabei Tang et al.
CLINICAL BIOCHEMISTRY (2013)
Reactive astrocytes promote the metastatic growth of breast cancer stem-like cells by activating Notch signalling in brain
Fei Xing et al.
EMBO MOLECULAR MEDICINE (2013)
The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer
Paul W. Sperduto et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
The Identification and Characterization of Breast Cancer CTCs Competent for Brain Metastasis
Lixin Zhang et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Sugar for the brain: the role of glucose in physiological and pathological brain function
Philipp Mergenthaler et al.
TRENDS IN NEUROSCIENCES (2013)
Metabolic interaction between cancer cells and stromal cells according to breast cancer molecular subtype
Junjeong Choi et al.
BREAST CANCER RESEARCH (2013)
Circulating Tumor Cells and Circulating Tumor DNA
Catherine Alix-Panabieres et al.
ANNUAL REVIEW OF MEDICINE, VOL 63 (2012)
Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse
J. Chuck Harrell et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Brain metastases after breast-conserving therapy and systemic therapy: incidence and characteristics by biologic subtype
Nils D. Arvold et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
The Blood-Brain Barrier: Its Influence in the Treatment of Brain Tumors Metastases
D. Fortin
CURRENT CANCER DRUG TARGETS (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Christina Curtis et al.
NATURE (2012)
Upregulation of VEGF-A and CD24 gene expression by the tGLI1 transcription factor contributes to the aggressive behavior of breast cancer cells
X. Cao et al.
ONCOGENE (2012)
Combined targeting of HER2 and VEGFR2 for effective treatment of HER2-amplified breast cancer brain metastases
David P. Kodack et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Receptor tyrosine kinase ErbB2 translocates into mitochondria and regulates cellular metabolism
Yan Ding et al.
NATURE COMMUNICATIONS (2012)
Integrin β4 Signaling Promotes Mammary Tumor Cell Adhesion to Brain Microvascular Endothelium by Inducing ErbB2-Mediated Secretion of VEGF
Jie Fan et al.
ANNALS OF BIOMEDICAL ENGINEERING (2011)
Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2011)
MicroRNA-1258 Suppresses Breast Cancer Brain Metastasis by Targeting Heparanase
Lixin Zhang et al.
CANCER RESEARCH (2011)
Methylation status of T-lymphoma invasion and metastasis 1 promoter and its overexpression in colorectal cancer
He Jin et al.
HUMAN PATHOLOGY (2011)
Notch1 Inhibition Alters the CD44hi/CD24lo Population and Reduces the Formation of Brain Metastases from Breast Cancer
Patricia M. McGowan et al.
MOLECULAR CANCER RESEARCH (2011)
Deconstructing the molecular portraits of breast cancer
Aleix Prat et al.
MOLECULAR ONCOLOGY (2011)
Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect
Cen Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
An overview of the c-MET signaling pathway
Shawna Leslie Organ et al.
Therapeutic Advances in Medical Oncology (2011)
Phosphatidylinositol 3-kinase pathway activation in breast cancer brain metastases
Barbara Adamo et al.
BREAST CANCER RESEARCH (2011)
Prognosis of Women With Metastatic Breast Cancer by HER2 Status and Trastuzumab Treatment: An Institutional-Based Review
Shaheenah Dawood et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Metastatic Behavior of Breast Cancer Subtypes
Hagen Kennecke et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Clinical and Imaging Features of Fludarabine Neurotoxicity
Michael S. Lee et al.
JOURNAL OF NEURO-OPHTHALMOLOGY (2010)
Epidermal Growth Factor-Induced Heparanase Nucleolar Localization Augments DNA Topoisomerase I Activity in Brain Metastatic Breast Cancer
Lixin Zhang et al.
MOLECULAR CANCER RESEARCH (2010)
Genome remodelling in a basal-like breast cancer metastasis and xenograft
Li Ding et al.
NATURE (2010)
Notch signalling in cancer stem cells
Victoria Bolos et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2009)
Targeting the mTOR Signaling Network for Cancer Therapy
Funda Meric-Bernstam et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Genes that mediate breast cancer metastasis to the brain
Paula D. Bos et al.
NATURE (2009)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
Notch Signaling Regulates Mammary Stem Cell Function and Luminal Cell-Fate Commitment
Toula Bouras et al.
CELL STEM CELL (2008)
Targeting integrin β4 for cancer and anti-angiogenic therapy
Filippo G. Giancotti
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Predominance of the basal type and HER-2/neu type in brain metastasis from breast cancer
Jochen Gaedcke et al.
MODERN PATHOLOGY (2007)
Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain
Diane Palmieri et al.
CANCER RESEARCH (2007)
Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer
Socorro M. Rodriguez-Pinilla et al.
MODERN PATHOLOGY (2007)
The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer
R. L. Dillon et al.
ONCOGENE (2007)
Mammary stem cells and breast cancer - Role of notch signalling
Gillian Farnie et al.
STEM CELL REVIEWS (2007)
TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer
Anita Langerod et al.
BREAST CANCER RESEARCH (2007)
Breast cancer-associated PIK3CA mutations are oncogenic in mammary epithelial cells
SJ Isakoff et al.
CANCER RESEARCH (2005)
Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer
DH Zhang et al.
MOLECULAR & CELLULAR PROTEOMICS (2005)
Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer
B Weigelt et al.
CANCER RESEARCH (2005)
Diagnostic evaluation of HER-2 as a molecular target: An assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials
MF Press et al.
CLINICAL CANCER RESEARCH (2005)
Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells
G Dontu et al.
BREAST CANCER RESEARCH (2004)
Regulation of hypoxia-inducible factor 1α expression and function by the mammalian target of rapamycin
CC Hudson et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Heparanase-1 expression is associated with the metastatic potential of breast cancer
JB Maxhimer et al.
SURGERY (2002)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Share Paper
